TSMC Nominates Two Ex-Chiefs of Big U.S. Companies to Board
By Kosaku Narioka
Taiwan Semiconductor Manufacturing Co. is nominating two former chiefs of major U.S. companies and a former premier of Taiwan to its board as it expands manufacturing capacity abroad amid diplomatic tensions between the U.S. and China.
The world's largest contract chip maker said Friday that it is nominating Ursula Burns, a former chief executive of Xerox, and Lynn Elsenhans, a former chief executive of U.S. gas company Sunoco, to its board, as well as Chuan Lin, a former Taiwanese premier.
TSMC said the three candidates, along with seven other current directors, will stand for election at its annual general shareholders' meeting on June 4.
Current directors Kok-Choo Chen and Yancey Hai will retire from the board, the company said.
TSMC previously said Chairman Mark Liu would step down after the shareholders' meeting.
Write to Kosaku Narioka at kosaku.narioka@wsj.com
(END) Dow Jones Newswires
April 12, 2024 03:56 ET (07:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track